The Docking Protein Gab1 is the Primary Mediator of EGF-stimulated Activation of the PI-3K/Akt Cell Survival Pathway
Overview
Affiliations
Background: Gab1 is a docking protein that recruits phosphatidylinositol-3 kinase (PI-3 kinase) and other effector proteins in response to the activation of many receptor tyrosine kinases (RTKs). As the autophosphorylation sites on EGF-receptor (EGFR) do not include canonical PI-3 kinase binding sites, it is thought that EGF stimulation of PI-3 kinase and its downstream effector Akt is mediated by an indirect mechanism.
Results: We used fibroblasts isolated from Gab1-/- mouse embryos to explore the mechanism of EGF stimulation of the PI-3 kinase/Akt anti-apoptotic cell signaling pathway. We demonstrate that Gab1 is essential for EGF stimulation of PI-3 kinase and Akt in these cells and that these responses are mediated by complex formation between p85, the regulatory subunit of PI-3 kinase, and three canonical tyrosine phosphorylation sites on Gab1. Furthermore, complex formation between Gab1 and the protein tyrosine phosphatase Shp2 negatively regulates Gab1 mediated PI-3 kinase and Akt activation following EGF-receptor stimulation. We also demonstrate that tyrosine phosphorylation of ErbB3 may lead to recruitment and activation of PI-3 kinase and Akt in Gab1-/- MEFs.
Conclusions: The primary mechanism of EGF-induced stimulation of the PI-3 kinase/Akt anti-apoptotic pathway occurs via the docking protein Gab1. However, in cells expressing ErbB3, EGF and neuroregulin can stimulate PI-3 kinase and Akt activation in a Gab1-dependent or Gab1-independent manner.
Nisha , Thapliyal D, Gohil B, Modak A, Singh N, Mukherjee C Mol Neurobiol. 2025; .
PMID: 40042729 DOI: 10.1007/s12035-025-04816-6.
Abe M, Yanagawa M, Hiroshima M, Kobayashi T, Sako Y Elife. 2024; 13.
PMID: 39513999 PMC: 11548882. DOI: 10.7554/eLife.101652.
Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).
PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.
Kong Y, Jiang R, Zhou H, Ge M, Lin H, Wang Y J Transl Med. 2024; 22(1):689.
PMID: 39075515 PMC: 11287983. DOI: 10.1186/s12967-024-05488-x.
Integrated proteogenomic characterization of glioblastoma evolution.
Kim K, Migliozzi S, Koo H, Hong J, Park S, Kim S Cancer Cell. 2024; 42(3):358-377.e8.
PMID: 38215747 PMC: 10939876. DOI: 10.1016/j.ccell.2023.12.015.